Marketing Psychiatric Drugs to Jailers and Judges
The Atlantic
During the twentieth century, pharmaceutical companies showed little interest in inmates. Then, in the 1980s and ’90s, “tough on crime” policies expanded the nation’s corrections population. Those developments had the unintended consequence of turning corrections into warehouses for the mentally ill. The relationship between drug companies and the criminal-justice system changed at the start of the millennium. Big pharmaceutical companies staged “product theaters” or “education luncheons” for correctional providers that show how their products could help treat inmates.